Stephanie Loiseau

Pharma marketing stands at a pivotal crossroads. The old playbooks, once built on caution and convention, are giving way to a new era defined by creativity, courage, and connected intelligence. To lead in 2026 and beyond, marketers must learn to innovate fearlessly while operating with uncompromising integrity and patient trust at the core.

This provocative discussion brings together boundary-pushing leaders who are rewriting the rules of engagement—challenging the status quo, dismantling silos, and redefining how innovation can coexist with regulation. The conversation will explore how AI, data transparency, and cultural transformation are unlocking a new kind of agility in pharma marketing: one that’s bold, compliant, and deeply human.

• Courage Over Comfort: Explore how forward-thinking organizations are reframing risk as a driver of creativity and competitive edge—without compromising ethics or compliance.
• Reimagining the Marketing Blueprint: Learn how innovators are transforming traditional channels and leveraging emerging technologies to create authentic, real-time connections with HCPs and patients.
• Building Trust in the Age of Transformation: Understand how transparency, empathy, and purpose-led storytelling are redefining trust as the true currency of pharma innovation.